Pharma's Market
SPECIAL REPORT
MOST SHARED
- Marc Faber: 100% Chance of Global Recession
- Zero China Growth Is ‘Probable’: Gordon Chang
- Citigroup Lost $20 Million on Facebook IPO Trades
- What College Tuition Will Look Like in 18 Years
- China Growth Risks Signal Need for Fiscal Action
- Romney Leads Poll Of Small Business Owners
- 5 Spots Where the Dollar Buys a Great Vacation
- How to Trade on the Jobs Report
- A New Look at the ‘New Poor’
- Six Pack: Beer Buzz of the Week
- Greek Exit Could Trigger 50% Fall in Euro Stocks: Analyst
- Under Pressure, FHA Skews to Wealthier Home Buyers
- Big Stock Upside for Hudson City Deal: Analyst
- 5 High-Yield Stocks Ready to Boost Dividends
- Yoshikami: Four Things You Need to Know About Gold Now
- Steinbock: The Euro Zone Endgame Begins
- Option Bulls Take Another Shot on Idenix
- Citigroup Lost $20 Million on Facebook IPO Trades
- Sticker Shock: What College Is Likely to Cost in 18 Years
- JPMorgan to Shake Up Risk Team After Big Loss: Report
- Icahn Raises Stake in Chesapeake, Wants Board Seats
- Marc Faber: Chance of Global Recession Is Now 100%
- Week Ahead: Europe Has Wall Street Bull on Short Leash
- What Happened to Stocks? Most Unloved in 50 Years
- Cool Jobs: From Gold Stacker to Bed Tester
- Many Greeks Moved Their Money Abroad Long Ago
RSS FEED
Credit Suisse Healthier 15: Investors Get Skinny On Fat Fighters
Text Size 
Reporter
 |
AP |
The firm assembled what it calls the "Obesity Team" made up not just of healthcare analysts, but also a whole bunch of consumer products analysts: 21 people in all.
The result is a comprehensive report that goes way beyond identifying all of the usual suspects in fat-fighting biopharmas for investors. It points out all sorts of somewhat counterintuitive investment ideas that could play a role in the obesity space that the team calls "The Credit Suisse Healthier 15." So, here are the stocks that made the cut:
(Two companies not listed in quote box are Kuala Lumpur Kepong (KLKK.KL) and Danone (DANO.PA).
Credit Suisse says it has gone so far as to create a basket of 12 of those stocks for investors who "would like to play the healthier living theme." HWAY, LULU and Kuala Lumpur are the three left on the sidelines. But the full report names dozens of healthcare and consumer-related stocks that could benefit from the fight against fat.
The healthcare analysts estimate that the obesity drug and device market will grow from $55 billion this year to $73 billion in 2012. The report points out that worldwide the number of obese or overweight people (1.8 billion) now exceeds the number of underfed people (1.1 billion, according to the Worldwatch Institute). And while the U.S. is believed to be the fattest country in the world, CS says the obese population of China between 2005 and 2015 is expected to explode 347%!
Credit Suisse says the "Obesity Team" report is part of its "New Perspective Series" where "research analysts join together, often times with the help of our equity strategists, to craft in-depth thematic analysis highlighting the issues at hand and the companies poised to benefit." At a time when many firms are cutting back on or cutting out their equities research it looks like Credit Suisse is--at least in this respect--fattening up.
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes
